Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that Forbes magazine has ranked ZOLL #87 on its list of the top 100 small public businesses in America with annual revenue between $5 million and $1 billion.
In the Forbes article published in the November 7 issue, it was stated: “For many small businesses, this economic ‘recovery’ has felt more like a tension headache that won’t go away. Then there are the 100 impressive outfits on the Forbes annual ranking of America’s best small public companies.” ZOLL is one of only 11 companies in the healthcare industry to make the list.
“Our longstanding commitment to improving resuscitation outcomes is driving our business forward. Our unique portfolio, including the LifeVest® Wearable Defibrillator, the AutoPulse® automated CPR device, the only defibrillator line fully equipped with real-time CPR feedback, and our leadership in post-resuscitation care is helping clinicians save more lives every day,” said Richard A. Packer, Chief Executive Officer of ZOLL. We are pleased to be recognized for our performance and to receive this designation from Forbes.”
To qualify for the Forbes Top Small Companies list, candidates must have been publicly traded for at least a year, generate annual revenue between $5 million and $1 billion, and boast a stock price no lower than $5 a share. The rankings are based on earnings growth, sales growth and return on equity in the past 12 months and over five years.
The full list can be viewed at forbes.com/best-small-companies/list/.
ZOLL’s innovative resuscitation, therapeutic temperature management, and data management products have been instrumental in improving the quality of critical care and increasing patient survival rates. ZOLL was the first company to introduce real-time CPR feedback with its Real CPR Help® technology. Its See-Thru CPR® filtering technology is another industry first. ZOLL’s industry-leading technology also includes the AutoPulse, which delivers high-quality, automated chest compressions; the LifeVest Wearable Defibrillator, which saves a life every other day; and ZOLL IVTM™, an intravascular approach to temperature management for cooling or warming critical care patients.
About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com) develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.
Certain statements contained in this press release, including statements regarding the anticipated development of the Company's business, our belief regarding growth in the capital equipment market, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 17, 2010 and updated in the Company’s Quarterly Reports on Form 10-Q filed subsequently to the Form 10-K, including the Form 10-Q Quarterly Report filed on August 8, 2011. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.
Copyright © 2011 ZOLL Medical Corporation. All rights reserved. AutoPulse, IVTM, LifeVest, Real CPR Help, See-Thru CPR, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. All trademarks are the property of their respective owners.
A. Ernest Whiton, Chief Financial Officer
P: +1 (978) 421-9655